Dr. Rohit Jain on factors affecting treatment selection in renal cell carcinoma


Rohit Jain, MD, Moffitt Cancer Center, discusses risk status and other factors he considers in treatment selection for patients with advanced renal cell carcinoma (RCC).

Note: this interview was filmed before the FDA approval of pembrolizumab plus lenvatinib for the first-line treatment of adult patients with advanced RCC.

Related Videos
Dr. Mayer Fishman in an interview with Urology Times
Dr. Laurence Albiges in an interview with Urology Times
Opioid pills | Image Credit: © BillionPhotos.com - stock.adobe.com
Craig G. Rogers, MD, answers a question during a Zoom video interview
Dr. Harras Zaid in an interview with Urology Times
Bottle of white pills | Image Credit - © leighannef - stock.adobe.com
Orange pill bottle with loose pills spilling out | Image Credit: © Antonio Rodriguez - stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.